Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
7.74
+0.01 (0.13%)
At close: May 20, 2026, 4:00 PM EDT
7.74
0.00 (0.00%)
After-hours: May 20, 2026, 4:00 PM EDT
Unicycive Therapeutics Market Cap
Unicycive Therapeutics has a market cap or net worth of $205.86 million as of May 20, 2026. Its market cap has increased by 163.48% in one year.
Market Cap
205.86M
Enterprise Value
151.82M
1-Year Change
163.48%
Ranking
Category
Stock Price
$7.74
Market Cap Chart
Since the IPO on July 13, 2021, Unicycive Therapeutics's market cap has increased from $66.49M to $205.86M, an increase of 209.61%. That is a compound annual growth rate of 26.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 206.39M | 66.44% |
| Dec 31, 2025 | 124.01M | 50.43% |
| Dec 31, 2024 | 82.44M | 173.36% |
| Dec 29, 2023 | 30.16M | 270.11% |
| Dec 30, 2022 | 8.15M | -73.58% |
| Dec 31, 2021 | 30.84M | -53.61% |
| Jul 13, 2021 | 66.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Codexis | 219.06M |
| Tonix Pharmaceuticals Holding | 218.71M |
| Foghorn Therapeutics | 217.83M |
| LENZ Therapeutics | 217.60M |
| Voyager Therapeutics | 215.10M |
| Innate Pharma | 212.73M |
| MediWound | 212.58M |
| Cybin | 212.15M |